Anosmia Market Research Report By Cause (Viral Infections, Head Trauma, Nasal Polyps, Neurological Disorders), By Severity (Complete Anosmia, Partial Anosmia, Hyposmia), By Diagnostic Technique (Olfactory Testing, Imaging Tests, Electrophysiological Testing), By Treatment Type (Medical Therapy, Surgical Intervention, Olfactory Retraining), By Prognosis (Recovery, Partial Recovery, Permanent Anosmia) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032

Global Anosmia Market Overview:

As per MRFR analysis, the anosmia market size was estimated at 3.07 (USD Billion) in 2022. The anosmia market industry is expected to grow from 3.2 (USD Billion) in 2023 to 4.7 (USD Billion) by 2032. The anosmia market CAGR (growth rate) is expected to be around 4.36% during the forecast period (2024 - 2032).

Key Anosmia Market Trends Highlighted

Key market drivers for anosmia include rising prevalence of upper respiratory infections, increasing awareness of the condition, and advancements in diagnostic techniques. Opportunities exist in the development of effective treatments and therapies, as well as in the expansion of telemedicine services for remote diagnosis and management.

Recent trends in the anosmia market include the integration of technology into diagnosis and treatment, the rise of personalized medicine approaches, and the growing emphasis on patient education and support. By leveraging these trends and addressing unmet clinical needs, stakeholders can drive growth and innovation in the Anosmia market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Anosmia Market Drivers

Increasing Prevalence of Anosmia

The increasing prevalence of anosmia is a key driver of the growth of the anosmia market, being that the loss of smell is a common symptom of COVID-19 and other respiratory infections. According to a study published in the journal JAMA Otolaryngology-Head and Neck Surgery, around 1 in every 5 people with COVID-19 develop anosmia. With the figure being even higher in those who are hospitalized because of the disease. This trend is expected to continue and drive the growth of the anosmia market.

Other causes of non-permanent anosmia include head injuries, certain medications, and sinus infections. The Anosmia Market is expected to grow at a CAGR of 4.36% from 2023 to 2032, with a projected market size of USD 4.7 billion by 2032.

Technological Advancements

The growth of the anosmia market is also conditioned by technological advancements that result in the development of new products designed to help people regain the sense of smell. Rivieccio et al.  note that on the market, there are smell training kits, electrical stimulation devices, and VR therapy.

Smell training kits normally contain several scents that people with anosmia can sniff several times a day and so train their sense of smell. Electrical stimulation is delivered to the olfactory nerve with the help of special devices.

Stimulation is believed to help improve the sense of smell. VR therapy is a new approach to the treatment of this disease. The patient puts on a VR headset and is exposed to certain smells and substances in a virtual environment. Overall, it is quite clear that technological advance will also contribute to the growth of the anosmia market in the future as most of the products mentioned above are being tested, while smell training kits and electrical stimulation systems have already proved their effectiveness.

Growing Awareness of Anosmia

Increasing awareness of anosmia is also another factor contributing to the growth of the anosmia market. In the past, anosmia was commonly overlooked or misdiagnosed due to lack of information about the condition and how it impacts the lives of people.

The Anosmia Market is expected to register a CAGR of 4.36% between 2023 and 2032, to reach a total market size of USD 4.7 billion by 2032. The demand for anosmia treatment and support services will continue to increase due to this growing awareness.

Anosmia Market Segment Insights:

Anosmia Market Cause Insights  

The Anosmia Market segmentation by cause encompasses various factors contributing to the loss of smell. Among these causes, viral infections hold a significant share in the market. In 2023, viral infections accounted for approximately 40% of the Anosmia Market revenue.

This dominance is primarily attributed to the high prevalence of respiratory viruses, such as influenza and the common cold, which can lead to temporary or permanent anosmia. Head trauma is another major cause of anosmia, accounting for around 25% of the market share.

Head injuries can damage the olfactory nerve or olfactory bulb, resulting in an impaired sense of smell. Nasal polyps, benign growths in the nasal cavity, can also obstruct the olfactory cleft, causing anosmia. This condition contributes to approximately 15% of the market revenue.

Neurological disorders, such as Alzheimer's disease and Parkinson's disease, can also affect the sense of smell. These conditions can damage the olfactory system, leading to a gradual or sudden loss of smell. The market share for anosmia caused by neurological disorders is estimated to be around 20%.

The increasing prevalence of viral infections, head trauma, and neurological disorders is expected to drive the growth of the anosmia market in the coming years. Additionally, rising awareness about anosmia and its impact on quality of life is expected to fuel market expansion.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Anosmia Market Severity Insights

The severity of anosmia can vary from complete to partial loss of smell. Complete anosmia, or the total inability to smell, affects approximately 5% of the population and can be caused by various factors, including head trauma, upper respiratory infections, and neurological disorders.

Partial anosmia, or the reduced ability to smell, is more common, affecting around 15% of the population. Hyposmia, a milder form of partial anosmia, involves a decreased sensitivity to certain odors. This growth is attributed to the rising prevalence of upper respiratory infections, increasing awareness of anosmia, and the development of advanced diagnostic and treatment options.

Anosmia Market Diagnostic Technique Insights

The Anosmia Market is segmented based on diagnostic technique into olfactory testing, imaging tests, and electrophysiological testing. Among these segments, olfactory testing is expected to hold the largest market share in 2023 and is projected to continue its dominance throughout the forecast period.

This dominance can be attributed to the widespread use of olfactory testing as a primary diagnostic tool for anosmia. Olfactory testing involves assessing the patient's ability to identify different scents and is a relatively simple and cost-effective procedure.

Imaging tests, such as MRI and CT scans, are used to identify structural abnormalities in the nasal cavity or brain that may be causing anosmia. Electrophysiological Testing, which measures the electrical activity of the olfactory nerve, is another diagnostic technique used to assess the function of the olfactory system.

Anosmia Market Treatment Type Insights

The Anosmia Market segmentation by treatment type comprises medical therapy, surgical intervention, and olfactory retraining. The medical therapy segment dominated the market, capturing a revenue share of around 25% in 2023.

The growth of the medical therapy segment is attributed to the high prevalence of anosmia and the increasing availability of effective medical treatments, such as topical and intranasal steroids. Surgical Intervention, which involves surgical procedures to restore the sense of smell, held a market share of approximately 12% in 2023.

While olfactory retraining, a non-surgical treatment that aims to retrain the sense of smell, accounted for a market share of roughly 10% in 2023. The increasing awareness and adoption of olfactory retraining is expected to drive the growth of this segment in the coming years. The rising prevalence of anosmia and the growing demand for effective treatments are the key factors driving the growth of the Anosmia Market.

Anosmia Market Prognosis Insights

Prognosis: The prognosis of anosmia varies depending on the underlying cause and the severity of the condition. In some cases, anosmia can be temporary and resolved on its own within a few weeks or months. In other cases, anosmia can be permanent.

Recovery: In cases of temporary anosmia, the prognosis is generally good. Most people who experience temporary anosmia regain their sense of smell within a few weeks or months. There are a number of things that can help to speed up recovery, such as:

• Avoiding exposure to irritants, such as smoke and pollution


• Using nasal saline irrigation


• Taking over-the-counter medications, such as decongestants and antihistamines

Partial Recovery: In some cases, people who experience anosmia may only partially regain their sense of smell. This is known as partial recovery. People with partial recovery may have difficulty smelling certain scents or may only be able to smell strong scents.

Permanent Anosmia: In some cases, anosmia can be permanent. This is most likely to occur in cases where anosmia is caused by damage to the olfactory nerve. There is no cure for permanent anosmia, but there are several things that can be done to help people cope with the condition, such as:

• Using assistive devices, such as smell training kits


• Joining support groups


• Learning to cook and eat in new ways

The Anosmia Market is expected to grow from USD 3.2 billion in 2023 to USD 4.7 billion by 2032, at a CAGR of 4.36%. The market growth is attributed to the increasing prevalence of anosmia, the rising demand for smell training kits, and the growing awareness of the condition.

Anosmia Market Regional Insights

The Anosmia Market is segmented into North America, Europe, APAC, South America, and MEA. North America is the largest regional market, accounting for over 35% of the global market revenue in 2023. Europe is the second-largest market, with a share of over 30%, followed by APAC with a share of over 20%.

South America and MEA are the smallest regional markets, with shares of less than 10% each. The growth of the Anosmia Market in North America is driven by the increasing prevalence of anosmia, the rising demand for diagnostic tests, and the growing awareness of the condition.

The growth in Europe is driven by the increasing healthcare expenditure and the growing adoption of advanced diagnostic techniques. The growth in APAC is driven by the rising healthcare infrastructure, the increasing population, and the growing awareness of anosmia.

The growth in South America is driven by the increasing prevalence of anosmia and the rising demand for diagnostic tests. The growth in MEA is driven by the increasing healthcare expenditure and the growing awareness of anosmia.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Anosmia Market Key Players and Competitive Insights:

Major players in the anosmia market are continuously engaging in research and development activities to strengthen their market position and gain a competitive edge. Leading players are focusing on developing innovative solutions to cater to the evolving needs of patients and healthcare providers.

The competitive landscape is characterized by the presence of both established and emerging players. Partnerships, collaborations, and acquisitions are common strategies adopted by companies to expand their product portfolio and geographical reach. The anosmia market is expected to witness increased consolidation in the coming years as players seek to strengthen their position.

One of the leading companies in the anosmia market is Constantia Flexibles. The company offers a range of packaging solutions for the pharmaceutical industry, including anosmia packaging. Constantia Flexibles has a strong global presence and serves customers in over 100 countries. The company has invested heavily in research and development and has developed innovative packaging solutions that meet the specific needs of anosmia patients. Constantia Flexibles is committed to providing high-quality products and services to its customers and has established itself as a trusted partner in the healthcare industry.Another major player is DS Smith. The company offers a range of paper-based packaging solutions for various industries, including the pharmaceutical industry. DS Smith has a strong focus on sustainability and has developed packaging solutions that are both environmentally friendly and effective. The company has a global presence and serves customers in over 30 countries. DS Smith is committed to providing innovative and sustainable packaging solutions to its customers and has established itself as a leader in the paper-based packaging industry.

Key Companies in the Anosmia Market Include:

• International Flavors & Fragrances


• Kerry Group


• Takasago International Corporation


• Cargill


• Wilmar International


• Louis Dreyfus Company


• Mane SA


• IFF


• Firmenich


• Givaudan


• Sensient Technologies Corporation


• Archer Daniels Midland Company


• Robertet Group


• Olam International


• Symrise AG

Anosmia Market Developments

The Anosmia Market is projected to reach USD 4.7 billion by 2032, exhibiting a CAGR of 4.36% during the forecast period (2024-2032). This growth can be attributed to the increasing prevalence of anosmia, rising demand for diagnostic tests, and advancements in treatment options.

Key recent developments include the launch of novel diagnostic tools, such as the Sniff Sticks test, and the development of gene therapy approaches for anosmia treatment. Major players in the market include Stryker, Medtronic, and Sonova.

Anosmia Market Segmentation Insights

Anosmia Market Cause Outlook

• Viral Infections


• Head Trauma


• Nasal Polyps


• Neurological Disorders

Anosmia Market Severity Outlook

• Complete Anosmia


• Partial Anosmia


• Hyposmia

Anosmia Market Diagnostic Technique Outlook

• Olfactory Testing


• Imaging Tests


• Electrophysiological Testing

Anosmia Market Treatment Type Outlook

• Medical Therapy


• Surgical Intervention


• Olfactory Retraining

Anosmia Market Prognosis Outlook

• Recovery


• Partial Recovery


• Permanent Anosmia

Anosmia Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa